Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Download

Total Articles

11
(from Reference Citation Analysis)

Article PDFs (2)

Cited by > 0 (9)

Searched Name

Josh N Vo

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Publication Title Analysis
Category Analysis

Results Analysis

Indexed Articles

Year Published

Show more Refine

Article Type

Show more Refine

Article Statistics

Refine

MESH Headings

Show more Refine

First Author

Show more Refine

First Author Affiliations

Show more Refine

Authors

Show more Refine

Publication Titles

Show more Refine

Grant Agencies

Show more Refine

Countries/Regions

Show more Refine

Affiliations

Show more Refine

Corresponding Author Affiliations

Show more Refine

Category

Show more Refine

Number

Citation Analysis

Xiao L, Parolia A, Qiao Y, Bawa P, Eyunni S, Mannan R, Carson SE, Chang Y, Wang X, Zhang Y, Vo JN, Kregel S, Simko SA, Delekta AD, Jaber M, Zheng H, Apel IJ, McMurry L, Su F, Wang R, Zelenka-Wang S, Sasmal S, Khare L, Mukherjee S, Abbineni C, Aithal K, Bhakta MS, Ghurye J, Cao X, Navone NM, Nesvizhskii AI, Mehra R, Vaishampayan U, Blanchette M, Wang Y, Samajdar S, Ramachandra M, Chinnaiyan AM. Author Correction: Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer. Nature 2024:10.1038/s41586-024-07393-1. [PMID: 38649489 DOI: 10.1038/s41586-024-07393-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/25/2024]

Affiliation(s)

Lanbo Xiao Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA
Abhijit Parolia Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA Molecular and Cellular Pathology Program, University of Michigan, Ann Arbor, MI, USA
Yuanyuan Qiao Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA
Pushpinder Bawa Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA
Sanjana Eyunni Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA Molecular and Cellular Pathology Program, University of Michigan, Ann Arbor, MI, USA
Rahul Mannan Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA
Sandra E Carson Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA
Yu Chang Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA
Xiaoju Wang Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA
Yuping Zhang Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA
Josh N Vo Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA
Steven Kregel Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA
Stephanie A Simko Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA
Andrew D Delekta Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA
Mustapha Jaber Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA
Heng Zheng Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA
Ingrid J Apel Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA
Lisa McMurry Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA
Fengyun Su Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA
Rui Wang Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA
Sylvia Zelenka-Wang Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA
Sanjita Sasmal Aurigene Discovery Technologies, Electronic City Phase II, Bangalore, India
Leena Khare Aurigene Discovery Technologies, Electronic City Phase II, Bangalore, India
Subhendu Mukherjee Aurigene Discovery Technologies, Electronic City Phase II, Bangalore, India
Chandrasekhar Abbineni Aurigene Discovery Technologies, Electronic City Phase II, Bangalore, India
Kiran Aithal Aurigene Discovery Technologies, Electronic City Phase II, Bangalore, India
Mital S Bhakta Dovetail Genomics, Scotts Valley, CA, USA
Jay Ghurye Dovetail Genomics, Scotts Valley, CA, USA
Xuhong Cao Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI, USA
Nora M Navone Department of Genitourinary Medical Oncology and the David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Alexey I Nesvizhskii Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA
Rohit Mehra Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA
Ulka Vaishampayan Department of Internal Medicine/Oncology, University of Michigan, Ann Arbor, MI, USA
Marco Blanchette Dovetail Genomics, Scotts Valley, CA, USA
Yuzhuo Wang Vancouver Prostate Centre, Vancouver, British Columbia, Canada Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, V6T 1Z3, Canada
Susanta Samajdar Aurigene Discovery Technologies, Electronic City Phase II, Bangalore, India
Murali Ramachandra Aurigene Discovery Technologies, Electronic City Phase II, Bangalore, India
Arul M Chinnaiyan Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA. Department of Pathology, University of Michigan, Ann Arbor, MI, USA. Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA. Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA. Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI, USA. Department of Urology, University of Michigan, Ann Arbor, MI, USA.

Collapse

Roberts HJ, Ji S, Picca A, Sanson M, Garcia M, Snuderl M, Schüller U, Picart T, Ducray F, Green AL, Nakano Y, Sturm D, Abdullaev Z, Aldape K, Dang D, Kumar-Sinha C, Wu YM, Robinson D, Vo JN, Chinnaiyan AM, Cartaxo R, Upadhyaya SA, Mody R, Chiang J, Baker S, Solomon D, Venneti S, Pratt D, Waszak SM, Koschmann C. Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations. Acta Neuropathol 2023;146:849-852. [PMID: 37851269 PMCID: PMC10627895 DOI: 10.1007/s00401-023-02640-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2023] [Revised: 09/27/2023] [Accepted: 09/28/2023] [Indexed: 10/19/2023]

Affiliation(s)

Holly J Roberts Department of Pediatrics, Michigan Medicine, Ann Arbor, MI, USA
Sunjong Ji Department of Pediatrics, Michigan Medicine, Ann Arbor, MI, USA
Alberto Picca Department of Neurology-2, Pitié-Salpêtrière University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France
Marc Sanson Department of Neurology-2, Pitié-Salpêtrière University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France Onconeurotek, AP-HP, Hôpital Pitié-Salpêtrière, 75013, Paris, France Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau et de la Moelle Épinière, ICM, Paris, France
Mekka Garcia Department of Neurology, NYU Langone Health, New York, NY, USA
Matija Snuderl Department of Pathology, NYU Langone Health, New York, NY, USA
Ulrich Schüller Research Institute Children's Cancer Center Hamburg, Hamburg, Germany Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Thiébaud Picart Department of Neurosurgical Oncology and Vascular Neurosurgery, Pierre Wertheimer Neurological and Neurosurgical Hospital, Hospices Civils de Lyon, Université Lyon 1, CRCL, UMR Inserm 1052, CNRS 5286, 69008, Lyon, France
François Ducray Neuro-Oncology Department, Hospices Civils de Lyon, Université Lyon 1, CRCL, UMR Inserm 1052, CNRS 5286, 69000, Lyon, France
Adam L Green Morgan Adams Foundation Pediatric Brain Tumor Research Program, Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA
Yoshiko Nakano Division of Brain Tumor Translational Research, National Cancer Center Research Institute, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan Department of Pediatric Hematology/Oncology, Osaka City General Hospital, Osaka, Japan
Dominik Sturm Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany Department of Pediatric Hematology, Oncology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany
Zied Abdullaev Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Kenneth Aldape Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Derek Dang Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA
Chandan Kumar-Sinha Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA
Yi-Mi Wu Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA
Dan Robinson Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA
Josh N Vo Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA
Arul M Chinnaiyan Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI, USA Department of Urology, University of Michigan, Ann Arbor, MI, USA Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA
Rodrigo Cartaxo Department of Pediatrics, Michigan Medicine, Ann Arbor, MI, USA
Santhosh A Upadhyaya Department of Pediatrics, Michigan Medicine, Ann Arbor, MI, USA
Rajen Mody Department of Pediatrics, Michigan Medicine, Ann Arbor, MI, USA
Jason Chiang Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA
Suzanne Baker Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA
David Solomon Department of Pathology, University of California, San Francisco, San Francisco, CA, USA
Sriram Venneti Department of Pediatrics, Michigan Medicine, Ann Arbor, MI, USA Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA
Drew Pratt Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Sebastian M Waszak Laboratory of Computational Neuro-Oncology, School of Life Sciences, Swiss Institute for Experimental Cancer Research, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland. Department of Neurology, University of California, San Francisco, San Francisco, CA, USA. EPFL SV ISREC UPWASZAK, AAB 238 (Batiment AAB), Station 19, 1015, Lausanne, Switzerland.
Carl Koschmann Department of Pediatrics, Michigan Medicine, Ann Arbor, MI, USA. University of Michigan, 3520D MSRB I, 1150 W Medical Center Dr, Ann Arbor, MI, 48109, USA.

Collapse

Harms PW, Verhaegen ME, Vo JN, Tien JC, Pratt D, Su F, Dhanasekaran SM, Cao X, Mangelberger D, VanGoor J, Choi JE, Ma VT, Dlugosz AA, Chinnaiyan AM. Viral Status Predicts the Patterns of Genome Methylation and Decitabine Response in Merkel Cell Carcinoma. J Invest Dermatol 2022;142:641-652. [PMID: 34474081 PMCID: PMC8860850 DOI: 10.1016/j.jid.2021.07.173] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2021] [Revised: 06/22/2021] [Accepted: 07/12/2021] [Indexed: 12/13/2022]

Affiliation(s)

Paul W. Harms Department of Pathology, University of Michigan, Ann Arbor, MI, 48109, USA,2Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, 48109, USA,3Rogel Cancer Center, University of Michigan, Ann Arbor, MI, 48109, USA,4Department of Dermatology, University of Michigan, Ann Arbor, MI, 48109, USA
Monique E. Verhaegen Department of Dermatology, University of Michigan, Ann Arbor, MI, 48109, USA
Josh N. Vo Department of Pathology, University of Michigan, Ann Arbor, MI, 48109, USA,2Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, 48109, USA
Jean C. Tien Department of Pathology, University of Michigan, Ann Arbor, MI, 48109, USA,2Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, 48109, USA
Drew Pratt Department of Pathology, University of Michigan, Ann Arbor, MI, 48109, USA
Fengyun Su Department of Pathology, University of Michigan, Ann Arbor, MI, 48109, USA,2Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, 48109, USA
Saravana M. Dhanasekaran Department of Pathology, University of Michigan, Ann Arbor, MI, 48109, USA,2Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, 48109, USA
Xuhong Cao Department of Pathology, University of Michigan, Ann Arbor, MI, 48109, USA,2Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, 48109, USA,5Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI, 48109, USA
Doris Mangelberger Department of Dermatology, University of Michigan, Ann Arbor, MI, 48109, USA
Julia VanGoor College of Literature, Science, and the Arts, University of Michigan, Ann Arbor, MI, 48109, USA
Jae Eun Choi Department of Pathology, University of Michigan, Ann Arbor, MI, 48109, USA,2Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, 48109, USA
Vincent T. Ma Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI, 48109, USA
Andrzej A. Dlugosz Rogel Cancer Center, University of Michigan, Ann Arbor, MI, 48109, USA,4Department of Dermatology, University of Michigan, Ann Arbor, MI, 48109, USA,8Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, MI, 48109, USA
Arul M. Chinnaiyan Department of Pathology, University of Michigan, Ann Arbor, MI, 48109, USA,2Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, 48109, USA,3Rogel Cancer Center, University of Michigan, Ann Arbor, MI, 48109, USA,5Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI, 48109, USA,9Department of Urology, University of Michigan, Ann Arbor, MI, 48109, USA,*Corresponding Author: Arul M. Chinnaiyan, M.D., Ph.D., Investigator, Howard Hughes Medical Institute, American Cancer Society Professor, S. P. Hicks Endowed Professor of Pathology, Rogel Cancer Center, University of Michigan Medical School, 1400 E. Medical Center Dr. 5316 CCGC, Ann Arbor, MI 48109-0602,

Collapse

Xiao L, Parolia A, Qiao Y, Bawa P, Eyunni S, Mannan R, Carson SE, Chang Y, Wang X, Zhang Y, Vo JN, Kregel S, Simko SA, Delekta AD, Jaber M, Zheng H, Apel IJ, McMurry L, Su F, Wang R, Zelenka-Wang S, Sasmal S, Khare L, Mukherjee S, Abbineni C, Aithal K, Bhakta MS, Ghurye J, Cao X, Navone NM, Nesvizhskii AI, Mehra R, Vaishampayan U, Blanchette M, Wang Y, Samajdar S, Ramachandra M, Chinnaiyan AM. Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer. Nature 2022;601:434-439. [PMID: 34937944 PMCID: PMC8770127 DOI: 10.1038/s41586-021-04246-z] [Citation(s) in RCA: 102] [Impact Index Per Article: 51.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2021] [Accepted: 11/15/2021] [Indexed: 12/13/2022]

Affiliation(s)

Lanbo Xiao Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA
Abhijit Parolia Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA Molecular and Cellular Pathology Program, University of Michigan, Ann Arbor, MI, USA
Yuanyuan Qiao Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA
Pushpinder Bawa Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA
Sanjana Eyunni Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA Molecular and Cellular Pathology Program, University of Michigan, Ann Arbor, MI, USA
Rahul Mannan Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA
Sandra E Carson Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA
Yu Chang Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA
Xiaoju Wang Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA
Yuping Zhang Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA
Josh N Vo Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA
Steven Kregel Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA
Stephanie A Simko Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA
Andrew D Delekta Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA
Mustapha Jaber Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA
Heng Zheng Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA
Ingrid J Apel Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA
Lisa McMurry Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA
Fengyun Su Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA
Rui Wang Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA
Sylvia Zelenka-Wang Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA
Sanjita Sasmal Aurigene Discovery Technologies, Electronic City Phase II, Bangalore, India
Leena Khare Aurigene Discovery Technologies, Electronic City Phase II, Bangalore, India
Subhendu Mukherjee Aurigene Discovery Technologies, Electronic City Phase II, Bangalore, India
Chandrasekhar Abbineni Aurigene Discovery Technologies, Electronic City Phase II, Bangalore, India
Kiran Aithal Aurigene Discovery Technologies, Electronic City Phase II, Bangalore, India
Mital S Bhakta Dovetail Genomics, Scotts Valley, CA, USA
Jay Ghurye Dovetail Genomics, Scotts Valley, CA, USA
Xuhong Cao Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI, USA
Nora M Navone Department of Genitourinary Medical Oncology and the David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Alexey I Nesvizhskii Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA
Rohit Mehra Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA Department of Pathology, University of Michigan, Ann Arbor, MI, USA Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA
Ulka Vaishampayan Department of Internal Medicine/Oncology, University of Michigan, Ann Arbor, MI, USA
Marco Blanchette Dovetail Genomics, Scotts Valley, CA, USA
Yuzhuo Wang Vancouver Prostate Centre, Vancouver, British Columbia, Canada Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, V6T 1Z3, Canada
Susanta Samajdar Aurigene Discovery Technologies, Electronic City Phase II, Bangalore, India
Murali Ramachandra Aurigene Discovery Technologies, Electronic City Phase II, Bangalore, India
Arul M Chinnaiyan Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA. Department of Pathology, University of Michigan, Ann Arbor, MI, USA. Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA. Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA. Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI, USA. Department of Urology, University of Michigan, Ann Arbor, MI, USA.

Collapse

Qiao Y, Choi JE, Tien JC, Simko SA, Rajendiran T, Vo JN, Delekta AD, Wang L, Xiao L, Hodge NB, Desai P, Mendoza S, Juckette K, Xu A, Soni T, Su F, Wang R, Cao X, Yu J, Kryczek I, Wang XM, Wang X, Siddiqui J, Wang Z, Bernard A, Fernandez-Salas E, Navone NM, Ellison SJ, Ding K, Eskelinen EL, Heath EI, Klionsky DJ, Zou W, Chinnaiyan AM. Autophagy Inhibition by Targeting PIKfyve Potentiates Response to Immune Checkpoint Blockade in Prostate Cancer. Nat Cancer 2021;2:978-993. [PMID: 34738088 PMCID: PMC8562569 DOI: 10.1038/s43018-021-00237-1] [Citation(s) in RCA: 40] [Impact Index Per Article: 13.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]

Affiliation(s)

Yuanyuan Qiao Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan 48109, USA.,2Department of Pathology, University of Michigan, Ann Arbor, Michigan 48109, USA.,3Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan 48109, USA
Jae Eun Choi Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan 48109, USA.,4School of Medicine, University of California, San Diego, California 92093, USA
Jean C. Tien Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan 48109, USA.,2Department of Pathology, University of Michigan, Ann Arbor, Michigan 48109, USA
Stephanie A. Simko Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan 48109, USA
Thekkelnaycke Rajendiran Department of Pathology, University of Michigan, Ann Arbor, Michigan 48109, USA.,5Michigan Regional Comprehensive Metabolomics Resource Core, Ann Arbor, Michigan 48109, USA
Josh N. Vo Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan 48109, USA.,6Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan 48109, USA
Andrew D. Delekta Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan 48109, USA
Lisha Wang Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan 48109, USA
Lanbo Xiao Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan 48109, USA
Nathan B. Hodge Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan 48109, USA
Parth Desai Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan 48109, USA
Sergio Mendoza Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan 48109, USA
Kristin Juckette Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan 48109, USA
Alice Xu Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan 48109, USA
Tanu Soni Michigan Regional Comprehensive Metabolomics Resource Core, Ann Arbor, Michigan 48109, USA
Fengyun Su Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan 48109, USA
Rui Wang Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan 48109, USA
Xuhong Cao Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan 48109, USA.,7Howard Hughes Medical Institute, University of Michigan, Ann Arbor, Michigan 48109, USA
Jiali Yu Department of Surgery, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA
Ilona Kryczek Department of Surgery, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA
Xiao-Ming Wang Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan 48109, USA.,2Department of Pathology, University of Michigan, Ann Arbor, Michigan 48109, USA
Xiaoju Wang Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan 48109, USA
Javed Siddiqui Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan 48109, USA
Zhen Wang School of Pharmacy, Jinan University, Guangzhou 510632, China
Amélie Bernard CNRS, Laboratoire de Biogenèse Membranaire, UMR5200; Université de Bordeaux, Laboratoire de Biogenèse Membranaire, UMR5200, 33000 Bordeaux, France.,11Life Sciences Institute and Department of Molecular, Cellular and Developmental Biology, University of Michigan, Ann Arbor, Michigan 48109, USA
Ester Fernandez-Salas Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan 48109, USA
Nora M. Navone Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
Stephanie J. Ellison Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan 48109, USA
Ke Ding School of Pharmacy, Jinan University, Guangzhou 510632, China
Eeva-Liisa Eskelinen Institute of Biomedicine, University of Turku, 20520 Turku, Finland
Elisabeth I. Heath Karmanos Cancer Institute, Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan 48201, USA
Daniel J. Klionsky Life Sciences Institute and Department of Molecular, Cellular and Developmental Biology, University of Michigan, Ann Arbor, Michigan 48109, USA
Weiping Zou Department of Pathology, University of Michigan, Ann Arbor, Michigan 48109, USA.,3Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan 48109, USA.,8Department of Surgery, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA
Arul M. Chinnaiyan Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan 48109, USA.,2Department of Pathology, University of Michigan, Ann Arbor, Michigan 48109, USA.,3Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan 48109, USA.,7Howard Hughes Medical Institute, University of Michigan, Ann Arbor, Michigan 48109, USA.,15Department of Urology, University of Michigan, Ann Arbor, Michigan 48109, USA.,*Correspondence to: Arul M. Chinnaiyan, Michigan Center for Translational Pathology, Rogel Cancer Center, 1500 East Medical Center Drive, Ann Arbor, Michigan 48109, USA. Phone: 734-615-4062; Fax: 734-615-4498;

Collapse

Harms KL, Zhao L, Johnson B, Wang X, Carskadon S, Palanisamy N, Rhodes DR, Mannan R, Vo JN, Choi JE, Chan MP, Fullen DR, Patel RM, Siddiqui J, Ma VT, Hrycaj S, McLean SA, Hughes TM, Bichakjian CK, Tomlins SA, Harms PW. Virus-positive Merkel Cell Carcinoma Is an Independent Prognostic Group with Distinct Predictive Biomarkers. Clin Cancer Res 2021;27:2494-2504. [PMID: 33547200 DOI: 10.1158/1078-0432.ccr-20-0864] [Citation(s) in RCA: 41] [Impact Index Per Article: 13.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2020] [Revised: 12/31/2020] [Accepted: 02/02/2021] [Indexed: 11/16/2022]

Affiliation(s)

Kelly L Harms Department of Dermatology, University of Michigan, Ann Arbor, Michigan.,Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan
Lili Zhao Department of Biostatistics, University of Michigan, Ann Arbor, Michigan
Bryan Johnson Strata Oncology, Ann Arbor, Michigan
Xiaoming Wang Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan.,Department of Pathology, University of Michigan, Ann Arbor, Michigan
Shannon Carskadon Department of Urology, Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan
Nallasivam Palanisamy Department of Urology, Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan
Daniel R Rhodes Strata Oncology, Ann Arbor, Michigan
Rahul Mannan Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan.,Department of Pathology, University of Michigan, Ann Arbor, Michigan
Josh N Vo Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan.,Department of Pathology, University of Michigan, Ann Arbor, Michigan
Jae Eun Choi Department of Pathology, University of Michigan, Ann Arbor, Michigan
May P Chan Department of Dermatology, University of Michigan, Ann Arbor, Michigan.,Department of Pathology, University of Michigan, Ann Arbor, Michigan
Douglas R Fullen Department of Dermatology, University of Michigan, Ann Arbor, Michigan.,Department of Pathology, University of Michigan, Ann Arbor, Michigan
Rajiv M Patel Department of Dermatology, University of Michigan, Ann Arbor, Michigan.,Department of Pathology, University of Michigan, Ann Arbor, Michigan
Javed Siddiqui Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan.,Department of Pathology, University of Michigan, Ann Arbor, Michigan
Vincent T Ma Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.,Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, Michigan
Steven Hrycaj Department of Pathology, University of Michigan, Ann Arbor, Michigan
Scott A McLean Department of Otolaryngology-Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan
Tasha M Hughes Department of Surgery, University of Michigan, Ann Arbor, Michigan
Christopher K Bichakjian Department of Dermatology, University of Michigan, Ann Arbor, Michigan.,Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan
Scott A Tomlins Strata Oncology, Ann Arbor, Michigan.,Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan.,Department of Pathology, University of Michigan, Ann Arbor, Michigan
Paul W Harms Department of Dermatology, University of Michigan, Ann Arbor, Michigan. .,Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.,Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan.,Department of Pathology, University of Michigan, Ann Arbor, Michigan

Collapse

Kumar-Sinha C, Anderson B, Heider A, Vo JN, Robinson DR, Wu YM, Chinnaiyan AM, Mody R. Clinical Sequencing of High-Grade Undifferentiated Sarcomas: A Case Series and Report of an Aggressive Primary Cardiac Tumor With Multiple Oncogenic Drivers. JCO Precis Oncol 2020;4:PO.19.00322. [PMID: 33015523 PMCID: PMC7529506 DOI: 10.1200/po.19.00322] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/13/2020] [Indexed: 11/20/2022] Open

Kregel S, Malik R, Asangani IA, Wilder-Romans K, Rajendiran T, Xiao L, Vo JN, Soni T, Cieslik M, Fernadez-Salas E, Zhou B, Cao X, Speers C, Wang S, Chinnaiyan AM. Functional and Mechanistic Interrogation of BET Bromodomain Degraders for the Treatment of Metastatic Castration-resistant Prostate Cancer. Clin Cancer Res 2019;25:4038-4048. [PMID: 30918020 DOI: 10.1158/1078-0432.ccr-18-3776] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2018] [Revised: 01/14/2019] [Accepted: 03/18/2019] [Indexed: 12/26/2022]

Affiliation(s)

Steven Kregel Michigan Center for Translational Pathology, University of Michigan.,Department of Pathology, University of Michigan, Ann Arbor, Michigan
Rohit Malik Michigan Center for Translational Pathology, University of Michigan.,Department of Pathology, University of Michigan, Ann Arbor, Michigan
Irfan A Asangani Michigan Center for Translational Pathology, University of Michigan.,Department of Pathology, University of Michigan, Ann Arbor, Michigan
Kari Wilder-Romans Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan
Thekkelnaycke Rajendiran Michigan Center for Translational Pathology, University of Michigan.,Department of Pathology, University of Michigan, Ann Arbor, Michigan
Lanbo Xiao Michigan Center for Translational Pathology, University of Michigan.,Department of Pathology, University of Michigan, Ann Arbor, Michigan
Josh N Vo Michigan Center for Translational Pathology, University of Michigan
Tanu Soni Division of Bioinformatics, Michigan Regional Comprehensive Metabolomics Resource Core, University of Michigan, Ann Arbor, Michigan
Marcin Cieslik Michigan Center for Translational Pathology, University of Michigan.,Department of Pathology, University of Michigan, Ann Arbor, Michigan
Ester Fernadez-Salas Michigan Center for Translational Pathology, University of Michigan.,Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, Michigan.,Departments of Internal Medicine, Pharmacology, and Medicinal Chemistry, University of Michigan, Ann Arbor, Michigan
Bing Zhou Michigan Center for Translational Pathology, University of Michigan.,Departments of Internal Medicine, Pharmacology, and Medicinal Chemistry, University of Michigan, Ann Arbor, Michigan.,Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan
Xuhong Cao Michigan Center for Translational Pathology, University of Michigan.,Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, Michigan
Corey Speers Michigan Center for Translational Pathology, University of Michigan.,Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.,Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan
Shaomeng Wang Michigan Center for Translational Pathology, University of Michigan.,Departments of Internal Medicine, Pharmacology, and Medicinal Chemistry, University of Michigan, Ann Arbor, Michigan.,Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan
Arul M Chinnaiyan Michigan Center for Translational Pathology, University of Michigan. .,Department of Pathology, University of Michigan, Ann Arbor, Michigan.,Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.,Department of Urology, University of Michigan, Ann Arbor, Michigan.,Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan

Collapse

Vo JN, Cieslik M, Zhang Y, Shukla S, Xiao L, Zhang Y, Wu YM, Dhanasekaran SM, Engelke CG, Cao X, Robinson DR, Nesvizhskii AI, Chinnaiyan AM. The Landscape of Circular RNA in Cancer. Cell 2019;176:869-881.e13. [PMID: 30735636 PMCID: PMC6601354 DOI: 10.1016/j.cell.2018.12.021] [Citation(s) in RCA: 998] [Impact Index Per Article: 199.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2018] [Revised: 10/05/2018] [Accepted: 12/12/2018] [Indexed: 12/17/2022]

Affiliation(s)

Josh N Vo Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI 48109, USA; Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI 48109, USA
Marcin Cieslik Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI 48109, USA; Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI 48109, USA
Yajia Zhang Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI 48109, USA; Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI 48109, USA
Sudhanshu Shukla Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI 48109, USA; Department of Biosciences and Bioengineering, Indian Institute of Technology Dharwad, Dharwad, 580011, India
Lanbo Xiao Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI 48109, USA
Yuping Zhang Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI 48109, USA
Yi-Mi Wu Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI 48109, USA
Saravana M Dhanasekaran Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI 48109, USA
Carl G Engelke Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI 48109, USA
Xuhong Cao Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI 48109, USA
Dan R Robinson Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI 48109, USA
Alexey I Nesvizhskii Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI 48109, USA; Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA; Rogel Cancer Center, University of Michigan, Ann Arbor, MI 48109, USA.
Arul M Chinnaiyan Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI 48109, USA; Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA; Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI 48109, USA; Rogel Cancer Center, University of Michigan, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA.

Collapse

Parolia A, Xiao L, Vo JN, Cieslik M, Cao X, Chinnaiyan AM. Abstract 975: Functional CRISPR screen towards identifying novel epigenetic co-factors of oncogenic AR-activity. Cancer Res 2018. [DOI: 10.1158/1538-7445.am2018-975] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]

Abstract Abstract Prostate cancer (PCa) is the second leading cause of cancer-related mortality in North American men. In recent years, there has been mounting evidence establishing the centrality of epigenetic mechanisms in PCa initiation and progression. Accordingly, various epigenetic genes have been described to collaborate with the androgen receptor (AR) in enabling its oncogenic transcriptional program and aberrantly restoring its activity in metastatic castration resistant PCa. Concordantly, our laboratory has recently described two epigenetic genes, BRD4 and MLL2, as key co-activators of AR-signaling. Furthermore, we have demonstrated that inhibition of these genes synergistically work with AR antagonists to attenuate PCa progression in preclinical models. Thus, in a setting where all metastatic patients eventually progress to evolve resistance to anti-AR therapies, there exists a dire clinical need to identify novel therapeutic targets. To this end, using CRISPR-Cas9 technology, we have engineered a unique AR-reporter LNCaP model that harbors the mCherry gene directly downstream of the endogenous KLK3/PSA promoter (a canonical AR-target). Notably, validation experiments confirm that the mCherry reporter gene, akin to KLK3, is dynamically regulated by AR activity in response to treatment with dihydrotestosterone (DHT; a physiological AR agonist) or enzalutamide (an AR inhibitor). Furthermore, we have designed a focused, high-depth library of small-guide RNAs (sgRNAs) to target over 200 distinct epigenetic genes, both at transcriptional start sites and functionally-essential enzymatic domains. Overall, this library comprises of roughly 1400 distinct guide-RNAs that include 50 non-targeting negative controls. Using these molecular tools, we plan to perform a marker-based, functional screen that involves the sorting of sgRNA-infected AR-reporter cells into mCherryHIGH and mCherryLOW populations. Notably, we have successfully validated the stated screening design: Starting from a mixed pool of AR-targeting siRNAs or R1881 (a synthetic AR-agonist) treated reporter cells, we sorted them into LOW15% or HIGH15% fractions based on the intensity of mCherry fluorescence. As expected, transcriptomic analyses of these fractions confirmed that AR-signaling was indeed significantly inhibited and enhanced in the LOW15% and HIGH15% fractions, respectively, relative to the unsorted cells. Thus, for our CRISPR screen, we theorize that the genomic interrogation of sgRNAs enriched in the mCherryLOW population will reveal novel epigenetic genes that function as essential co-factors of oncogenic AR-activity. These epigenetic factors can be co-targeted to extort durable therapeutic responses in patients treated with the current line of anti-AR therapies, thus directly addressing an urgent clinical need. Citation Format: Abhijit Parolia, Lanbo Xiao, Josh N. Vo, Marcin Cieslik, Xuhong Cao, Arul M. Chinnaiyan. Functional CRISPR screen towards identifying novel epigenetic co-factors of oncogenic AR-activity [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 975. Collapse

Vo JN, Zhang Y, Shukla S, Xiao L, Robinson D, Wu YM, Gao S, Engelke C, Cao X, Nesvizhskii A, Chinnaiyan A. Abstract 3288: The landscape of circular RNA in cancer. Cancer Res 2018. [DOI: 10.1158/1538-7445.am2018-3288] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]